These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 1700771)

  • 1. Natural killer cellular cytotoxicity against herpes simplex virus-infected cells in Igh-1-disparate mice.
    Tamesis RR; Foster CS
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2224-9. PubMed ID: 1700771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus type 1 in Igh-1 disparate congenic mice.
    Tamesis RR; Rodriguez A; Hoang-Xuan T; Foster CS
    Ger J Ophthalmol; 1993 Aug; 2(4-5):218-23. PubMed ID: 8220102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C; Lopez C
    J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of NK cells in mice following corneal infection with herpes simplex virus type-1.
    Brandt CR; Salkowski CA
    Invest Ophthalmol Vis Sci; 1992 Jan; 33(1):113-20. PubMed ID: 1370438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral isolation and systemic immune responses after intracameral inoculation of herpes simplex virus type 1 in Igh-1-disparate congenic murine strains.
    Hemady R; Tauber J; Ihley TM; Opremcak EM; Foster CS
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2335-41. PubMed ID: 2173686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV; Welsh RM; Haspel MV
    J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High cytotoxic activity against herpes simplex virus type 1 infected targets found in murine peritoneum.
    Brownridge E; Lopez C
    Nat Immun Cell Growth Regul; 1986; 5(6):294-304. PubMed ID: 2432414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1.
    Bukowski JF; Welsh RM
    J Immunol; 1986 May; 136(9):3481-5. PubMed ID: 2420892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenetic influence of Igh-1 phenotype on experimental herpes simplex virus type-1 corneal infection.
    Opremcak EM; Wells PA; Thompson P; Daigle JA; Rice BA; Millin JA; Foster CS
    Invest Ophthalmol Vis Sci; 1988 May; 29(5):749-54. PubMed ID: 3366566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of susceptibility of HSV-1-infected cells to natural killer lysis by interferon.
    Muñoz A; Carrasco L; Fresno M
    J Immunol; 1983 Aug; 131(2):783-7. PubMed ID: 6190939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo significance of NK cell on resistance against virus (HSV-1) infections in mice.
    Habu S; Akamatsu K; Tamaoki N; Okumura K
    J Immunol; 1984 Nov; 133(5):2743-7. PubMed ID: 6207244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of natural killer cells in the development of herpes simplex virus type 1 induced stromal keratitis in mice.
    Tamesis RR; Messmer EM; Rice BA; Dutt JE; Foster CS
    Eye (Lond); 1994; 8 ( Pt 3)():298-306. PubMed ID: 7958034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
    Bukowski JF; Welsh RM
    J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysis of herpes simplex virus (HSV) infected targets. III. Effect of HSV on natural killer activity.
    Hendricks RL; Sugar J
    Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):201-7. PubMed ID: 2579040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative mechanisms of natural killer cell activation during herpes simplex virus infection.
    Paya CV; Schoon RA; Leibson PJ
    J Immunol; 1990 Jun; 144(11):4370-5. PubMed ID: 2160501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of interferon in human natural killer activity against target cells infected with HSV-1.
    Bishop GA; Glorioso JC; Schwartz SA
    J Immunol; 1983 Oct; 131(4):1849-53. PubMed ID: 6194217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 2 induced non MHC-restricted killing of herpes simplex type-1 (HSV-1) infected allogeneic and autologous lymphoblasts.
    Klimpel GR; Asuncion M; Fons M; Norton JD; Albrecht T; Klimpel KD; Stein MD
    J Clin Lab Immunol; 1989 May; 29(1):1-7. PubMed ID: 2560794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus.
    Bukowski JF; Biron CA; Welsh RM
    J Immunol; 1983 Aug; 131(2):991-6. PubMed ID: 6190947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of interferon in natural kill of HSV-1-infected fibroblasts.
    Fitzgerald PA; von Wussow P; Lopez C
    J Immunol; 1982 Aug; 129(2):819-23. PubMed ID: 6177785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.